Fidaxomicin Drug Interactions
Currently displaying a list of 150 drugs known to interact with fidaxomicin.
- 3 major drug interactions
- 80 moderate drug interactions
- 67 minor drug interactions
Medications known to interact with fidaxomicin
Note: Showing generic names only.
A
- abrocitinib
- adagrasib
- afatinib
- aliskiren
- alpelisib
- alvimopan
- amiodarone
- apalutamide
- asciminib
- astemizole
- atezolizumab
- atorvastatin
- avacopan
- avelumab
B
- bepridil
- berotralstat
- betrixaban
- bifidobacterium infantis
- bifidobacterium longum
- binimetinib
- boceprevir
- bosutinib
- brigatinib
C
- cabozantinib
- capmatinib
- cemiplimab
- ceritinib
- cholera vaccine, live
- clarithromycin
- cobimetinib
- colchicine
- cosibelimab
- cyclosporine
D
- dabigatran
- daclatasvir
- danicopan
- daridorexant
- darolutamide
- diltiazem
- dostarlimab
- dronedarone
- durvalumab
E
F
G
H
I
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lapatinib
- larotrectinib
- lasmiditan
- lenacapavir
- levacetylleucine
- lomitapide
- loperamide
- lurasidone
- lusutrombopag
M
N
P
- pacritinib
- pazopanib
- pembrolizumab
- pemigatinib
- pexidartinib
- pirtobrutinib
- ponatinib
- pralsetinib
- pretomanid
- progesterone
- propafenone
- prucalopride
Q
R
S
- saquinavir
- sarecycline
- selpercatinib
- silodosin
- sirolimus
- sorafenib
- sotorasib
- sparsentan
- spironolactone
- suvorexant
T
- tacrolimus
- talazoparib
- tamoxifen
- telaprevir
- telithromycin
- tenofovir alafenamide
- tenofovir disoproxil
- tepotinib
- ticagrelor
- tislelizumab
- tolvaptan
- topotecan
- toripalimab
- tremelimumab
- treosulfan
- troleandomycin
- tucatinib
- typhoid vaccine, live
U
V
Report options
QR code containing a link to this page
More about fidaxomicin
- fidaxomicin consumer information
- Check interactions
- Compare alternatives
- Reviews (20)
- Side effects
- Dosage information
- During pregnancy
- Drug class: macrolides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
